Richard G. Jones
Accountancy in Baltimore, MD
License number
Maryland CC-0004846
Issued Date
Jun 3, 2004
Category
Accountancy
Type
C.P.A. Certificate
Address
Address
2
Baltimore, MD 21230
Personal information
See more information about Richard G. Jones at radaris.comName
Address
Phone
506 Tern Ct, Hvre De Grace, MD 21078
5109 Kings Rd, Saint Leonard, MD 20685
5013 Columbia Rd APT 201, Columbia, MD 21044
Professional information
See more information about Richard G. Jones at trustoria.com
Business Process Owner, Staffing Operations
Business Process Owner, Staffing Operations
Position:
Business Process Owner - Staffing Operations at TEKsystems, Inc.
Location:
Baltimore, Maryland Area
Industry:
Information Technology and Services
Work:
TEKsystems, Inc.
- Hanover, MD since Apr 2006
-
Business Process Owner - Staffing Operations
TEKsystems, Inc
- Baltimore, Maryland Area Jul 2001 - Apr 2006
-
Professional Recruiter (Information Technology)
TEKsystems, Inc.
- Washington D.C. Metro Area Jan 2001 - Jul 2001
-
Account Manager (Information Technology)
TEKsystems, Inc.
- Baltimore, Maryland Area Jan 2000 - Jan 2001
-
Consultant Services Coordinator (Information Technology)
TEKsystems, Inc.
- Baltimore, Maryland Area Apr 1999 - Jan 2000
-
Recruiter (Information Technology)
Education:
Towson University
Skills:
Change Management, Market Research, Staff Augmentation, Business Process Improvement, Technical Recruiting, Internet Recruiting, Business Systems Analysis, Data Analysis, Business Analysis, Management, Sourcing, Vendor Management, Training, Staffing Services, Talent Acquisition, Applicant Tracking Systems, Integration, Recruiting, Performance Management, Human Resources, SDLC
Awards:
Support Leader of the Year
TEKsystems
TEKsystems
Richard G. Jones
Richard G. Jones
Position:
Owner at Ricks Rehabs / Infinitile, President at Ricks Rehabs and Home Improvement / Infinitile-Masonry and Ceramics
Location:
Baltimore, Maryland Area
Industry:
Construction
Work:
Ricks Rehabs / Infinitile
-
Owner
Ricks Rehabs and Home Improvement / Infinitile-Masonry and Ceramics
since Mar 2007
-
President
Associate Principal At Mahan Rykiel Associates
Associate Principal At Mahan Rykiel Associates
Position:
Associate Principal at Mahan Rykiel Associates
Location:
Baltimore, Maryland Area
Industry:
Design
Work:
Mahan Rykiel Associates
-
Associate Principal
LDR International, Inc.
1998 - 2002
-
landscape arch
Education:
University of Maryland College Park 1994 - 1998
BA, Landscape Architecture Giessen American High School
BA, Landscape Architecture Giessen American High School
Richard Jones
Richard Jones
Specialties:
Buyer's Agent, Listing Agent
Work:
819 Baltimore St, Baltimore 21207
Manager At Jones Inc
Manager At Jones Inc
Position:
manager at Jones Inc
Location:
Baltimore, Maryland Area
Industry:
Accounting
Work:
Jones Inc
-
manager
Dr. Richard J Jones, Baltimore MD - MD (Doctor of Medicine)
Dr. Richard J Jones, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Sidney Kiml Comprhnsve Cncr Ctr
1650 Orleans St SUITE 244, Baltimore 21287
(410) 955-8964 (Phone)
1650 Orleans St SUITE 244, Baltimore 21287
(410) 955-8964 (Phone)
Certifications:
Internal Medicine, 1981, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Temple University
Graduated: 1978
Johns Hopkins Hospital
Temple University Hospital
Temple University
Graduated: 1978
Johns Hopkins Hospital
Temple University Hospital
Richard G. Jones
Richard G. Jones
Location:
Baltimore, Maryland Area
Education:
Princeton Theological Seminary 1988 - 1992
M.Div. Alderson-Broaddus College 1985 - 1988
B.A., Religious Studies/Psychology/Sociology
M.Div. Alderson-Broaddus College 1985 - 1988
B.A., Religious Studies/Psychology/Sociology
Methods For Identifying Leukemia Stem Cells And Distinguishing Them From Normal Hematopietic Stem Cells In Patients With Acute Myeloid Leukemia: Uses In Diagnosis, Treatment, And Research
Methods For Identifying Leukemia Stem Cells And Distinguishing Them From Normal Hematopietic Stem Cells In Patients With Acute Myeloid Leukemia: Uses In Diagnosis, Treatment, And Research
US Patent:
2013007, Mar 28, 2013
Filed:
Sep 24, 2012
Appl. No.:
13/625369
Inventors:
Jonathan Michael Gerber - Baltimore MD, US
Richard John Jones - Baltimore MD, US
Richard John Jones - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
C12Q 1/32
US Classification:
514789, 435 26
Abstract:
Using the methods of the present invention, intermediate (int) levels of aldehyde dehydrogenase (ALDH) activity reliably distinguished leukemic CD34CD38 cells capable of engrafting immunodeficient mice, from residual normal hematopoietic stem cells that exhibited relatively higher ALDH activity. Minimal residual disease (MRD) detected during complete remission was enriched for the CD34CD38ALDHleukemic cells, and the presence of these cells after therapy highly correlated with subsequent clinical relapse. The methods of the present invention can distinguish normal from leukemic CD34CD38 cells, and identifies those AML cells associated with relapse. Methods of prediction of relapse of AML patients and methods of treatment are also provided.
Cyclophosphamide In Combination With Immune Therapeutics
Cyclophosphamide In Combination With Immune Therapeutics
US Patent:
2012010, Apr 26, 2012
Filed:
Sep 14, 2011
Appl. No.:
13/232326
Inventors:
Robert A. Brodsky - Brooklandville MD, US
Richard J. Jones - Baltimore MD, US
Richard F. Ambinder - Baltimore MD, US
Richard J. Jones - Baltimore MD, US
Richard F. Ambinder - Baltimore MD, US
Assignee:
Accentia Biopharmaceuticals, Inc. - Tampa FL
The Johns Hopkins University - Baltimore MD
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 31/675, A61P 35/00, A61P 37/06
US Classification:
4241841
Abstract:
The present invention relates to methods of treating a cancer and in particular, a B-cell derived cancer, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug, either alone, or in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens.
Use Of High-Dose Oxazaphosphorine Drugs In Combination With Monoclonal Antibodies For Treating Immune Disorders
Use Of High-Dose Oxazaphosphorine Drugs In Combination With Monoclonal Antibodies For Treating Immune Disorders
US Patent:
2012012, May 24, 2012
Filed:
Sep 22, 2011
Appl. No.:
13/240465
Inventors:
Robert A. Brodsky - Brooklandville MD, US
Richard J. Jones - Baltimore MD, US
Susan Bonitz - Flemington NJ, US
Carlos Santos - Tampa FL, US
Adam Kaplin - Baltimore MD, US
Richard J. Jones - Baltimore MD, US
Susan Bonitz - Flemington NJ, US
Carlos Santos - Tampa FL, US
Adam Kaplin - Baltimore MD, US
Assignee:
Accentia Biopharmaceuticals, inc. - Tampa FL
The Johns Hopkins University - Baltimore MD
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 39/395, A61P 37/00
US Classification:
4241531
Abstract:
The present invention relates to methods of treating an autoimmune disorder, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens.